Yang Z - Search Results

1

miR-9 regulation of BRCA1 and ovarian cancer sensitivity to cisplatin and PARP inhibition.

Sun C, Li N, Yang Z, Zhou B, He Y, Weng D, Fang Y, Wu P, Chen P, Yang X, Ma D, Zhou J, Chen G. Sun C, et al. Among authors: yang x, yang z. J Natl Cancer Inst. 2013 Nov 20;105(22):1750-8. doi: 10.1093/jnci/djt302. Epub 2013 Oct 29. J Natl Cancer Inst. 2013. PMID: 24168967

2

Safety of ovarian preservation in young patients with early-stage endometrial cancer: a retrospective study and meta-analysis.

Sun C, Chen G, Yang Z, Jiang J, Yang X, Li N, Zhou B, Zhu T, Wei J, Weng D, Ma D, Wang C, Kong B. Sun C, et al. Among authors: yang x, yang z. Fertil Steril. 2013 Sep;100(3):782-7. doi: 10.1016/j.fertnstert.2013.05.032. Epub 2013 Jul 3. Fertil Steril. 2013. PMID: 23830105 Free article.

3

miR-222 is upregulated in epithelial ovarian cancer and promotes cell proliferation by downregulating P27^kip1.

Sun C, Li N, Zhou B, Yang Z, Ding D, Weng D, Meng L, Wang S, Zhou J, Ma D, Chen G. Sun C, et al. Among authors: yang z. Oncol Lett. 2013 Aug;6(2):507-512. doi: 10.3892/ol.2013.1393. Epub 2013 Jun 13. Oncol Lett. 2013. PMID: 24137356 Free PMC article.

4

Activation of integrin β1 mediates the increased malignant potential of ovarian cancer cells exerted by inflammatory cytokines.

Yang Z, Zhou X, Liu Y, Gong C, Wei X, Zhang T, Ma D, Gao Q. Yang Z, et al. Anticancer Agents Med Chem. 2014;14(7):955-62. doi: 10.2174/1871520614666140613123108. Anticancer Agents Med Chem. 2014. PMID: 24931361

5

Quercetin induces endoplasmic reticulum stress to enhance cDDP cytotoxicity in ovarian cancer: involvement of STAT3 signaling.

Yang Z, Liu Y, Liao J, Gong C, Sun C, Zhou X, Wei X, Zhang T, Gao Q, Ma D, Chen G. Yang Z, et al. FEBS J. 2015 Mar;282(6):1111-25. doi: 10.1111/febs.13206. Epub 2015 Feb 11. FEBS J. 2015. Retraction in: FEBS J. 2022 Feb;289(4):1149. doi: 10.1111/febs.16341. PMID: 25611565 Free article. Retracted.

6

Co-targeting EGFR and Autophagy Impairs Ovarian Cancer Cell Survival during Detachment from the ECM.

Yang Z, Liu Y, Wei X, Zhou X, Gong C, Zhang T, Jin P, Xu S, Ma D, Gao Q. Yang Z, et al. Curr Cancer Drug Targets. 2015;15(3):215-26. doi: 10.2174/1568009615666150126161939. Curr Cancer Drug Targets. 2015. PMID: 25619386

7

[Suppression of ATR reverses the cisplatin resistance in ovarian cancer SKOV3 cells].

Yang Z, Sun C, Liu Y, Gong C, Chen G, Weng D. Yang Z, et al. Zhonghua Zhong Liu Za Zhi. 2014 Nov;36(11):805-10. Zhonghua Zhong Liu Za Zhi. 2014. PMID: 25620475 Chinese.

8

A chemotherapy response classifier based on support vector machines for high-grade serous ovarian carcinoma.

Sun CY, Su TF, Li N, Zhou B, Guo ES, Yang ZY, Liao J, Ding D, Xu Q, Lu H, Meng L, Wang SX, Zhou JF, Xing H, Weng DH, Ma D, Chen G. Sun CY, et al. Oncotarget. 2016 Jan 19;7(3):3245-54. doi: 10.18632/oncotarget.6569. Oncotarget. 2016. PMID: 26675546 Free PMC article.

9

MARCKS contributes to stromal cancer-associated fibroblast activation and facilitates ovarian cancer metastasis.

Yang Z, Xu S, Jin P, Yang X, Li X, Wan D, Zhang T, Long S, Wei X, Chen G, Meng L, Liu D, Fang Y, Chen P, Ma D, Gao Q. Yang Z, et al. Among authors: yang x. Oncotarget. 2016 Jun 21;7(25):37649-37663. doi: 10.18632/oncotarget.8726. Oncotarget. 2016. PMID: 27081703 Free PMC article.

10

miR-17 inhibits ovarian cancer cell peritoneal metastasis by targeting ITGA5 and ITGB1.

Gong C, Yang Z, Wu F, Han L, Liu Y, Gong W. Gong C, et al. Among authors: yang z. Oncol Rep. 2016 Oct;36(4):2177-83. doi: 10.3892/or.2016.4985. Epub 2016 Jul 28. Oncol Rep. 2016. PMID: 27499367

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48,970 results

Search Page

Filters